Detrol LA Capsule 2 mg (Tolterodine L-Tartrate)

Adult dose

Adults: The usual dose is 4 mg of tolterodine L-tartrate taken orally once daily. Patients with renal impairment, hepatic impairment, or receiving ketoconazole or other potent CYP3A4 inhibitors: The dose is 2 mg once daily. If adverse reactions occur, the dose may be reduced from 4 mg to 2 mg once daily. This medicine may be taken with or without food. Swallow the dosage form whole; do not crush or split it.

This medication should not be used in patients with urinary retention symptoms or gastrointestinal issues, uncontrolled specific glaucoma patients, patients with allergies to this medication or its components, patients with severe myasthenia gravis, and patients with severe colitis or megacolon. It should be used with caution in patients at risk of urinary retention, those with gastrointestinal obstruction diseases, renal or hepatic dysfunction, patients taking specific antibiotics, antifungals, immunosuppressants, patients with dysautonomia, and those at risk of reduced gastrointestinal motility. This medication may cause side effects such as dry mouth, dyspepsia, and decreased tear production, and various adverse reactions such as infections, allergic reactions, mental confusion, drowsiness, dizziness, headache, constipation, abdominal pain, urinary issues, chest pain, weight gain, fatigue, vision abnormalities, skin rashes, etc. have been reported. Particularly, patients at risk of QT interval prolongation, patients taking specific antiarrhythmic medications, patients with electrolyte imbalances, and patients with bradycardia should exercise caution, and co-administration with strong CYP3A4 inhibitors should be avoided. This medication may affect the ability to drive or operate machinery, so caution is necessary. Additionally, concomitant use with other antimuscarinic medications may increase the effects, and drug interactions may occur with medications related to specific metabolic pathways, so consultation with healthcare professionals is required. It is advisable for pregnant or nursing women not to take this medication, and particularly for women who may become pregnant to use appropriate contraception. Safety in children has not been established, so its use is not recommended. In case of overdose, serious symptoms such as vision impairment and urinary difficulties may occur, so immediate medical attention should be sought for proper treatment. This medication should be kept out of reach of children and should not be transferred to other containers for safety.

• dry mouth
• indigestion
• reduced tear production
• bronchitis
• allergic reactions
• confusion
• drowsiness
• dizziness
• headache
• neurosis

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, it is recommended to store the medication in a cool place, specifically at room temperature below 25 degrees Celsius. Storing it this way helps maintain the medication's efficacy for a longer time.

Appearance

A capsule with blue-green upper and lower parts containing granules of off-white color

Package unit

30 capsules/bottle